Pfizer targets 2028 for its first obesity drug approval Company plans to advance more than 20 obesity trials in 2026 RSV vaccine quarterly sales top expectations Feb 3 (Reuters) - Pfizer (PFE.N), ...

By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug from its recent $10 billion Metsera purchase that raises questions about its ...

Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile ‌obesity drug from its recent $10 billion Metsera purchase that raises ‌questions about its tolerability for patients, and ...

Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” ...

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.

Online telehealth company Hims & Hers Health, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky ...

Because measles is so contagious, experts say that vaccination rates need to be above about 95 percent to stem the spread of ...

Achieve Life Sciences is a late-stage pharma company awaiting FDA approval for Cytisinicline, a novel smoking cessation ...